The research on Pelacarsen, a promising lipid-lowering agent, shows that it has no significant efficacy in reducing the risk of cardiovascular diseases in patient studies, which dims hopes for a broader application in the treatment of elevated Lp(a) levels. #Blutfettsenker #LipoproteinA #Herzgesundheit (translated)
The novel blood lipid-lowering drug Pelacarsen has shown no therapeutic benefit in clinical studies, which significantly dampens hopes for an effective treatment of elevated lipoprotein(a) levels and associated cardiovascular risks. #Blutfettsenker #Herzgesundheit #Lipoprotein (translated)